In the latest episode of The HemOnc Pulse, podcast host Chadi Nabhan, MD, MBA, FACP, talks with Elizabeth Brem, MD, Associate Clinical Professor in the School of Medicine at the University of California, Irvine, off the heels of the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition. Dr. Brem tells us which chronic lymphocytic leukemia (CLL) abstracts cannot be ignored from ASH 2022, the latest news in Richter’s Transformation, and why she is moving away from ibrutinib in her own clinical practice.